8-K - PHGE - Equibles

UNITEDSTATES

SECURITIESAND EXCHANGE COMMISSION

Washington,D.C. 20549

Form8-K

CURRENTREPORT

Pursuantto Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 3, 2020

BiomX Inc.
(Exact<br> Name of Registrant as Specified in its Charter)
Delaware	0001-38762	82-3364020
---	---	---
(State<br> or other jurisdiction<br><br> of incorporation)	(Commission<br> File Number)	(I.R.S.<br> Employer<br><br> Identification No.)
7 Pinhas Sapir St., Floor 2 Ness Ziona, Israel	7414002
---	---
(Address<br> of Principal Executive Offices)	(Zip<br> Code)

Registrant’s telephone number, including area code: (972) 72-394-2377

n/a
(Former<br> name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
---	---
☐	Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
---	---
☐	Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
---	---

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units,<br> each consisting of one share of Common Stock, $0.0001 par value, and one Warrant entitling the holder to receive one half<br> share of Common Stock	PHGE.U	NYSE<br> American
Shares<br> of Common Stock, $0.0001 par value, included as part of the Units	PHGE	NYSE<br> American
Warrants<br> included as part of the Units	PHGE.WS	NYSE<br> American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item5.07. Submission of Matters to a Vote of Security Holders.

On June 3, 2020, BiomX Inc. (the “Company”) held its 2020 Annual Meeting of Stockholders. At the meeting, stockholders voted in favor of all items of business, as indicated below:

ProposalNo. 1—Election of Directors

The Company’s stockholders voted to elect the following persons to the board of directors of the Company as Class I, II and III directors to serve until the 2021, 2022 and 2023 Annual Meetings of Stockholders, respectively:

Nominee	Class
Yaron Breski	I	9,749,813	99.94	5,399	0.06	857,327
Erez Chimovits	I	9,752,813	99.98	2,399	0.02	857,327
Dr. Gbola Amusa	II	9,752,638	99.97	2,574	0.03	857,327
Jonas Grossman	II	9,752,713	99.97	2,499	0.03	857,327
Dr. Russell Greig	III	9,752,813	99.98	2,399	0.02	857,327
Jonathan Solomon	III	9,752,813	99.98	2,399	0.02	857,327
Lynne Sullivan	III	9,752,738	99.97	2,474	0.03	857,327

ProposalNo. 2—Ratification of Selection of Independent Registered Public Accounting Firm For Fiscal 2020

The Company’s stockholders voted to ratify the selection of Brightman Almagor Zohar & Co. as the independent registered public accounting firm for the fiscal year ending December 31, 2020.

Votes For		% Votes For		Vote Against		% Votes Against		Abstain		Broker Non-Votes
	10,611,073		100.00		0		0.00		1,466		0

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	BIOMX INC.
June<br> 8, 2020	By:	/s/<br> Jonathan Solomon
		Name: Jonathan<br> Solomon
		Title: Chief<br> Executive Officer